| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6001141 | Thrombosis Research | 2015 | 7 Pages |
Abstract
The QOL in patients with VTE and AF is strongly reduced directly after the start of anticoagulant treatment, but improves within 3Â months. Moreover, QOL is influenced by demographic and disease-specific variables. These findings provide useful information for future cost-effectiveness studies.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Camilla L. Marvig, Talitha I. Verhoef, Anthonius de Boer, Farhad Kamali, Ken Redekop, Munir Pirmohamed, Ann K. Daly, Vangelis G. Manolopoulos, Mia Wadelius, Marcel Bouvy, Anke H. Maitland-van der Zee,